Clean bill of health for giant bird skeleton
The skeleton of the heavy-footed moa, an enormous flightless bird which once roamed parts of New Zealand 570 years ago, were first brought to the city in 1868.
At the time the skeleton was the only example of the species in the country outside the British Museum in London.
The remains have now been carefully cleaned by experts and checked over for signs of deterioration to ensure the bird can continue to be seen by future generations.
According to Leeds Museum, the bird was brought to West Yorkshire after it was acquired by Henry Denny, the then curator of the Leeds Philosophical and Literary Society.
Like many objects in the Leeds collection, it was damaged in 1941 after Philosophical Hall - then the city's museum - was bombed during World War II.
In 2011 curators rediscovered the bird's bones and, after a full restoration, they were put on display in the Leeds City Museum's collectors cabinet.
Driven to extinction by hunting and deforestation around 570 years ago, the species was one of the largest birds which ever existed, standing almost 6ft (1.8m) tall and weighing more than 300 lbs (136kg).
Clare Brown, Leeds Museums and Galleries' curator of natural sciences, said: "The moa is a truly historic specimen which really captures the imagination and brings a completely different world inhabited by extinct and bizarre giants to life.
"Having animals like this on display is not only a fascinating glimpse into a bygone era, it's a thought-provoking reminder of our responsibility to do what we can to protect the natural world both now and in the future."
The moa is one of a number of extinct species on display at the museum including a dodo and giant Irish elk.
Listen to highlights from West Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
More stories like this
Rare butterfly collection goes on display
Museum launches 'choose your own price' admission
Stuffed hippo helps reveal science of whiskers
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
a day ago
- Medscape
Hidden Late-Onset SpA in PMR: Who Are These Patients?
TOPLINE: Patients initially diagnosed with polymyalgia rheumatica (PMR) but later reclassified as having spondyloarthritis (SpA) showed bone marrow edema of the spine and sacroiliac joints on MRI. They also responded poorly to glucocorticoid therapy or were unable to taper off steroids and were more likely to benefit from treatment using TNF inhibitors or interleukin-17 (IL-17) inhibitors. METHODOLOGY: Researchers at a hospital in Leeds, England, screened patients with psoriatic arthritis or axial SpA to identify those who were initially diagnosed with PMR from 2002 to 2024. They analyzed the data of 31 patients (median age, 62 years; 17 women) who fulfilled standard diagnostic criteria for PMR and were subsequently diagnosed with SpA. Conventional radiography, MRI of the spine and sacroiliac joints, and FDG PET-CT were performed to confirm a diagnosis of SpA in patients with PMR and to exclude those with other conditions. TAKEAWAY: Among the 31 patients, 12 (38.7%) were diagnosed with SpA within 3 months of initial presentation, whereas the remaining 19 (61.3%) received their diagnosis after a median follow-up duration of 3 years due to persistent musculoskeletal symptoms and failure to taper glucocorticoids. The presence of psoriasis and a family history of SpA were associated with an early diagnosis of SpA. On MRI, bone marrow edema — a hallmark of SpA — was evident in the sacroiliac joints of 17 patients, the spine of 15 patients, and both sites in 20 patients. Symptoms of PMR completely resolved in 21 of 31 patients following initial glucocorticoid therapy, whereas 10 patients showed a clinically partial response to glucocorticoid therapy. Additionally, seven of the 21 initial responders experienced disease flares during follow-up (median duration, 5 years). During follow-up, one third of the patients were started on biologics such as anti-TNF-alfa and anti-IL-17 agents, both of which are recommended first-line treatments for axial SpA; at the last visit, eight patients were receiving conventional disease-modifying antirheumatic drugs, and 11 were receiving biologics. IN PRACTICE: 'In PMR cases with refractory symptoms or difficult GC [glucocorticoid] reduction, these findings raise the possibility that MRI may have a role in more accurate identification of a subset of PMR/SpA overlap, with potential treatment implications,' the authors wrote. SOURCE: The study was led by Kerem Abacar, MD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds. It was published online on July 22, 2025, in Arthritis & Rheumatology. LIMITATIONS: This study did not discuss any limitations. DISCLOSURES: No financial support was received for this study. Some authors declared receiving grants, contracts, consulting fees, payments or honoraria, and support for attending meetings or having other ties with various pharmaceutical companies. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
TechCrunch
5 days ago
- TechCrunch
Rocket Lab eyes big defense opportunities with new acquisition
Rocket Lab is signaling to investors, yet again, that it's more than 'just' a rocket company. Rocket Lab's second-quarter results, which were posted Thursday, show revenues continue to be driven by its space systems business rather than launch. The results also highlighted the company's acquisition strategy and how its purchase of a new optical payloads company will make it more competitive for lucrative government contracts. The company's space systems brought in $97.9 million of the $144.5 million in total revenues for the second quarter. Rocket Labs' total revenue, its highest quarterly revenue in the company's history, jumped 36% from a year ago. The company's net loss widened to $66.4 million. Rocket Lab founder and CEO Peter Beck highlighted the 'busy quarter of M&A activity' as the company is gets close to closing its deal to buy Geost, a company that builds optical payloads. Through that acquisition, which will close at $275 million in cash and equity, Rocket Lab is opening a new business unit called Optical Systems to scale electro-optical and infrared sensor manufacturing. Those sensors are used in missile warning, tracking, and space domain awareness. The acquisition is also one part of a larger play from Rocket Lab – spelled out quite explicitly in the company's earnings presentation – to bid for multi-billion-dollar DOD initiatives like Golden Dome. Rocket Lab has already won some major defense contracts, including a $515 million, 18-satellite build contract to support the Space Development Agency's constellation of missile tracking satellites. The company has moved into production on those satellites, following confirmation that they meet the DOD's mission requirements, Rocket Lab said. Down on Earth, Rocket Lab says its progressing well toward the first launch of its larger Neutron rocket. The rocket's launch complex in Virginia is expected to be complete in the third quarter of this year, with hardware en route and the new rocket engine, called Archimedes, undergoing multiple tests per day. Techcrunch event Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital, Elad Gil — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $600+ before prices rise. Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. San Francisco | REGISTER NOW The company is staying vague about the exact launch date, saying only in the presentation that it is pushing an 'all-out effort to get Neutron to the launch pad before the end of 2025.' Rocket Lab ended the quarter with $564 million in cash and cash equivalents and estimates revenues will hit between $145 to $155 million next quarter.
Yahoo
6 days ago
- Yahoo
Antarctica evacuation: US researchers flown in high-risk winter night operation
Three staff members from a United States research base in Antarctica were medically evacuated to New Zealand during extreme cold and dark conditions amid the southern winter, New Zealand's air force said Wednesday, Aug. 6. The U.S. National Science Foundation requested an emergency evacuation for three people unable to receive necessary care on the continent, including one who required urgent treatment, according to the New Zealand Defense Force. Despite high-risk travel conditions, the flight landed successfully and all three received treatment. "With the support of Antarctica New Zealand and United States' National Science Foundation staff in Antarctica, we have been able to complete the flight and the patients are now getting the medical treatment they need in Christchurch," Air Component Commander Air Commodore Andy Scott said in the Aug. 6 news release Following detailed analysis of weather conditions and the airfield, the Royal New Zealand Air Force aircraft flew from the McMurdo Station on Tuesday afternoon, Aug. 5, and landed in Christchurch, New Zealand, the next morning. One doctor and other medical personnel with the New Zealand Defence Force were onboard to care for the patients throughout the flight, the agency said. The military group did not provide any details about why each staff member required medical treatment. Why was the trip so dangerous? The military group stated that mid-winter flights in Antarctica are among the most challenging trips due to extreme cold, variable weather conditions, and the difficulty of landing an aircraft on the ice during the dark hours. Temperatures at the McMurdo Station were as low as -24 Celsius (-11 Fahrenheit) on Aug. 6, Reuters reported. The crew used night vision goggles to navigate the essentially pitch-black trip, and the U.S. Antarctic Program Winter Team physically created a runway ahead of takeoff to ensure the aircraft could safely land, according to Scott. "Although they determine it is safe, it's still an extremely challenging environment to fly in," Scott said. "This, coupled with there being no airfields available to divert to once the aircraft is past a certain point south adds to the risk, so these missions are not taken lightly." The trip took nearly 20 hours, including a brief stint on the ice to refuel while the aircraft engines continued to run in a process known as "hot refueling," the New Zealand Defense Force said. This article originally appeared on USA TODAY: US researchers evacuated from Antarctica in risky winter night flight Solve the daily Crossword
